Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

AMTI

Applied Molecular Transp... (AMTI)

Applied Molecular Transport Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AMTI
日付受信時刻ニュースソース見出しコード企業名
2023/01/0420 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
2022/12/2307 : 30GlobeNewswire Inc.Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
2022/12/2307 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
2022/12/0707 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/12/0707 : 00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/12/0706 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/11/1023 : 10Dow Jones NewsApplied Molecular Transport Gets New FDA Orphan Drug DesignationNASDAQ:AMTIApplied Molecular Transport Inc
2022/11/1022 : 00GlobeNewswire Inc.Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of PouchitisNASDAQ:AMTIApplied Molecular Transport Inc
2022/11/1013 : 25TipRanksSVB Securities Remains a Buy on Applied Molecular Transport (AMTI)NASDAQ:AMTIApplied Molecular Transport Inc
2022/11/0822 : 00GlobeNewswire Inc.Applied Molecular Transport to Present at Upcoming November Investor ConferencesNASDAQ:AMTIApplied Molecular Transport Inc
2022/11/0806 : 15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMTIApplied Molecular Transport Inc
2022/11/0806 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
2022/11/0806 : 01GlobeNewswire Inc.Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:AMTIApplied Molecular Transport Inc
2022/09/2021 : 00GlobeNewswire Inc.Applied Molecular Transport Completes Enrollment of Phase 2 LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
2022/09/0708 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/09/0708 : 24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/09/0708 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/09/0708 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/09/0708 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
2022/08/0904 : 55TipRanksJMP Securities Sticks to Its Buy Rating for Applied Molecular Transport (AMTI)NASDAQ:AMTIApplied Molecular Transport Inc
2022/08/0505 : 15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMTIApplied Molecular Transport Inc
2022/08/0505 : 11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
2022/08/0505 : 01GlobeNewswire Inc.Applied Molecular Transport Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:AMTIApplied Molecular Transport Inc
2022/07/0906 : 00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AMTIApplied Molecular Transport Inc
2022/07/0811 : 48TipRanksSVB Securities Thinks Applied Molecular Transport’s Stock is Going to RecoverNASDAQ:AMTIApplied Molecular Transport Inc
2022/07/0703 : 05TipRanksApplied Molecular Transport (AMTI) Receives a Buy from JMP SecuritiesNASDAQ:AMTIApplied Molecular Transport Inc
2022/07/0621 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
2022/07/0621 : 00GlobeNewswire Inc.Applied Molecular Transport Announces Top-line Phase 2 Results from MARKET Combination Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
2022/07/0605 : 01GlobeNewswire Inc.Applied Molecular Transport to Report Top-line Phase 2 Results from MARKET Combination Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
2022/06/0408 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
 Showing the most relevant articles for your search:NASDAQ:AMTI

最近閲覧した銘柄

Delayed Upgrade Clock